<DOC>
	<DOCNO>NCT00406367</DOCNO>
	<brief_summary>Patients receive one injection incobotulinumtoxinA ( Xeomin ) placebo baseline . Thereafter , patient enter Open-Label Extension Period ( OLEX ) receive five injection session incobotulinumtoxinA ( Xeomin ) OLEX period .</brief_summary>
	<brief_title>IncobotulinumtoxinA ( Xeomin ) Versus Placebo Treatment Blepharospasm</brief_title>
	<detailed_description />
	<mesh_term>Blepharospasm</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>Main Male female pretreated outpatient age 18 80 year ( inclusive ) A clinical diagnosis bilateral blepharospasm ( BEB ) characterize spontaneous , spasmodic , intermittent persistent involuntary contraction orbicular oculi muscle A need injection Botulinum toxin ( define Jankovic Rating Scale ( JRS ) severity subscore &gt; = 2 ) On stable dose medication ( ) use focal dystonia treatment ( e.g . anticholinergic benzodiazepine ) least 3 month prior expect throughout Main Period Source documentation last two consecutive injection session BOTOX® stable satisfactory therapeutic response directly prior trial entry At least 10 week must pass last injection BOTOX® BEB Baseline Main Atypical variant BEB cause inhibition levator palpebrae muscle Myotomy denervation surgery affect muscle ( e.g . peripheral denervation and/or spinal cord stimulation ) The previous two injection BOTOX® 50 Units per eye Hypersensitivity human serum albumin , sucrose , Botulinum toxin A Neuroleptic induce blepharospasm Diagnosis myasthenia gravis , LambertEaton syndrome , amyotrophic lateral sclerosis , significant neuromuscular disease might interfere trial Treatment Botulinum toxins indication BEB within 4 month prior Baseline trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>